Literature DB >> 8849346

Negatively charged residues interacting with the p4 pocket confer binding specificity to DRB1*0401.

S L Woulfe1, C P Bono, M L Zacheis, D A Kirschmann, T A Baudino, C Swearingen, R W Karr, B D Schwartz.   

Abstract

OBJECTIVE: To identify critical residues involved in the binding of a selective peptide to DRB1*0401.
METHODS: The binding of peptides to native or site-directed mutant DR molecules was evaluated using enzyme-linked immunosorbent assay and flow cytometry.
RESULTS: Amino acid substitutions at DR and peptide residues, which were predicted to contribute to interactions within the DR p4 pocket, had the greatest effects on the specificity of binding.
CONCLUSION: Differences in the peptide-binding repertoires of DR molecules may contribute to associations with autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8849346     DOI: 10.1002/art.1780381207

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  7 in total

1.  Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease.

Authors:  Chu-Young Kim; Hanne Quarsten; Elin Bergseng; Chaitan Khosla; Ludvig M Sollid
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-12       Impact factor: 11.205

2.  Subtle conformational changes induced in major histocompatibility complex class II molecules by binding peptides.

Authors:  A V Chervonsky; R M Medzhitov; L K Denzin; A K Barlow; A Y Rudensky; C A Janeway
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

3.  Repertoire-scale determination of class II MHC peptide binding via yeast display improves antigen prediction.

Authors:  C Garrett Rappazzo; Brooke D Huisman; Michael E Birnbaum
Journal:  Nat Commun       Date:  2020-09-04       Impact factor: 14.919

4.  Synthetic amino acid copolymers that bind to HLA-DR proteins and inhibit type II collagen-reactive T cell clones.

Authors:  M Fridkis-Hareli; E F Rosloniec; L Fugger; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

5.  Amidolytic and peptidolytic activities of immunoglobulin G present in sera from patients with rheumatoid arthritis, Sjogren's syndrome and systemic lupus erythematosus.

Authors:  K Matsuura; S Ikoma; M Sugiyama; M Funauchi; H Sinohara
Journal:  Immunology       Date:  1998-09       Impact factor: 7.397

6.  Restricted MHC-peptide repertoire predisposes to autoimmunity.

Authors:  Nadezda N Logunova; Christophe Viret; Leonid A Pobezinsky; Sara A Miller; Dmitri B Kazansky; John P Sundberg; Alexander V Chervonsky
Journal:  J Exp Med       Date:  2005-07-04       Impact factor: 14.307

Review 7.  Design of peptide immunotherapies for MHC Class-II-associated autoimmune disorders.

Authors:  Masha Fridkis-Hareli
Journal:  Clin Dev Immunol       Date:  2013-11-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.